IMVT Competitors & Alternatives
Compare Immunovant Inc with similar stocks in the same industry
Biotechnology
IMVT
Main Stock$33.65
Tradestie Score
56
Market Cap
$2.85B
Analyst Upside
+45.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$233.01
|
$8.30B | 15.8 | 61 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$65.62
|
$6.68B | - | 58 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$93.41
|
$6.64B | - | 54 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$95.10
|
$6.38B | - | 63 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.32
|
$6.03B | - | 55 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$55.44
|
$6.02B | - | 55 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$182.07
|
$5.92B | - | 44 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.62
|
$5.80B | 20.4 | 51 | Compare |
More IMVT Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry